🚀 VC round data is live in beta, check it out!
- Public Comps
- Centene
Centene Valuation Multiples
Discover revenue and EBITDA valuation multiples for Centene and similar public comparables like SBI Life Insurance, Humana Inc., NN Group, Loews Corporation and more.
Centene Overview
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Founded
1993
HQ

Employees
61.1K
Website
Sectors
Financials (LTM)
EV
$20B
Centene Financials
Centene reported last 12-month revenue of $194B and EBITDA of $1B.
In the same LTM period, Centene generated $171B in gross profit, $1B in EBITDA, and $1B in net income.
Revenue (LTM)
Centene P&L
In the most recent fiscal year, Centene reported revenue of $195B and EBITDA of $1B.
Centene expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $194B | XXX | $195B | XXX | XXX | XXX |
| Gross Profit | $171B | XXX | $14B | XXX | XXX | XXX |
| Gross Margin | 88% | XXX | 7% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | 0% | XXX | 0% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Centene Stock Performance
Centene has current market cap of $22B, and enterprise value of $20B.
Market Cap Evolution
Centene's stock price is $44.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20B | $22B | 0.0% | XXX | XXX | XXX | $2.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCentene Valuation Multiples
Centene trades at 0.1x EV/Revenue multiple, and 14.9x EV/EBITDA.
EV / Revenue (LTM)
Centene Financial Valuation Multiples
As of March 24, 2026, Centene has market cap of $22B and EV of $20B.
Equity research analysts estimate Centene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Centene has a P/E ratio of 19.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22B | XXX | $22B | XXX | XXX | XXX |
| EV (current) | $20B | XXX | $20B | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | 14.9x | XXX | 16.0x | XXX | XXX | XXX |
| EV/EBIT | 33.3x | XXX | 49.6x | XXX | XXX | XXX |
| EV/Gross Profit | 0.1x | XXX | 1.4x | XXX | XXX | XXX |
| P/E | 19.7x | XXX | 21.3x | XXX | XXX | XXX |
| EV/FCF | 5.1x | XXX | 4.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Centene Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Centene Margins & Growth Rates
Centene's revenue in the last 12 month declined by (2%).
Centene's revenue per employee in the last FY averaged $3.2M.
Centene's rule of 40 is (1%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Centene's rule of X is (4%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Centene Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (2%) | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 34% | XXX | 32% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (1%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (4%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $3.2M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | — | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Centene Public Comps
See public comps and valuation multiples for other Insurance Carriers comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SBI Life Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| Humana Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| NN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Loews Corporation | XXX | XXX | XXX | XXX | XXX | XXX |
| QBE Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Centene M&A Activity
Centene acquired XXX companies to date.
Last acquisition by Centene was on XXXXXXXX, XXXXX. Centene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Centene
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCentene Investment Activity
Centene invested in XXX companies to date.
Centene made its latest investment on XXXXXXXX, XXXXX. Centene invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Centene
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Centene
| When was Centene founded? | Centene was founded in 1993. |
| Where is Centene headquartered? | Centene is headquartered in United States. |
| How many employees does Centene have? | As of today, Centene has over 61K employees. |
| Who is the CEO of Centene? | Centene's CEO is Sarah M. London. |
| Is Centene publicly listed? | Yes, Centene is a public company listed on NYSE. |
| What is the stock symbol of Centene? | Centene trades under CNC ticker. |
| When did Centene go public? | Centene went public in 2001. |
| Who are competitors of Centene? | Centene main competitors are SBI Life Insurance, Humana Inc., NN Group, Loews Corporation. |
| What is the current market cap of Centene? | Centene's current market cap is $22B. |
| What is the current revenue of Centene? | Centene's last 12 months revenue is $194B. |
| What is the current revenue growth of Centene? | Centene revenue growth (NTM/LTM) is (2%). |
| What is the current EV/Revenue multiple of Centene? | Current revenue multiple of Centene is 0.1x. |
| Is Centene profitable? | Yes, Centene is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Centene? | Centene's last 12 months EBITDA is $1B. |
| What is Centene's EBITDA margin? | Centene's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Centene? | Current EBITDA multiple of Centene is 14.9x. |
| What is the current FCF of Centene? | Centene's last 12 months FCF is $4B. |
| What is Centene's FCF margin? | Centene's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Centene? | Current FCF multiple of Centene is 5.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.